CNR2 and obesity due to melanocortin 4 receptor deficiency: CB2 has also been detected in metabolic tissues, like adipose tissue and skeletal muscle [34, 35] and CB2 pharmacological or genetic inactivation in murine obesity models promote insulin-mediated glucose uptake in skeletal muscles, reduce adipose tissue inflammation, and thus improves insulin sensitivity [36, 37].